Polycationic Peptides Improve β-Lactam Antibiotics Against Enterococci
Author Information
Author(s): Werner Julia, Umstätter Florian, Böhmann Manuel B., Müller Hannah, Beijer Barbro, Hertlein Tobias, Kaschnitz Laura, Bram Veronika, Kleist Christian, Klika Karel D., Mühlberg Eric, Braune Gabriel, Wohlfart Sabrina, Gärtner Martin, Peter Silke, Zimmermann Stefan, Haberkorn Uwe, Ohlsen Knut, Brötz‐Oesterhelt Heike, Mier Walter, Uhl Philipp
Primary Institution: Heidelberg University Hospital
Hypothesis
Can conjugating polycationic peptides to β-lactam antibiotics enhance their efficacy against antibiotic-resistant enterococci?
Conclusion
The study found that β-lactam–peptide conjugates significantly increased antimicrobial activity against enterococci, offering a promising treatment strategy.
Supporting Evidence
- The β-lactam–peptide conjugates showed up to a 1000-fold increase in antimicrobial activity against enterococci.
- Conjugation resulted in altered killing mechanisms compared to parent β-lactam antibiotics.
- The conjugates were effective against both vancomycin-susceptible and vancomycin-resistant enterococci.
- Peptide modification led to different pharmacokinetics, with significant liver accumulation.
- CTZ-R6 treatment reduced bacterial burden in the liver of infected mice compared to CTZ.
Takeaway
Scientists made a new medicine by sticking special proteins to antibiotics, making them work better against superbugs that usually resist treatment.
Methodology
The study involved synthesizing β-lactam–peptide conjugates and testing their antimicrobial activity against various bacterial strains.
Potential Biases
Potential bias in the selection of bacterial strains and the interpretation of antimicrobial activity results.
Limitations
The study primarily focused on in vitro and in vivo models, which may not fully represent clinical outcomes.
Participant Demographics
Mice were used in the in vivo efficacy studies.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website